105 related articles for article (PubMed ID: 17142042)
21. Vascular Endothelial Growth Factor and Erythropoietin Show Different Expression Patterns in the Early and Late Hypoxia Preconditioning Phases and May Correlate with DNA Methylation Status in the Mouse Hippocampus.
Liu N; Zhang Y; Zhang P; Gong K; Zhang C; Sun K; Shao G
High Alt Med Biol; 2022 Dec; 23(4):361-368. PubMed ID: 36449395
[TBL] [Abstract][Full Text] [Related]
22. Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.
Post DE; Van Meir EG
Gene Ther; 2001 Dec; 8(23):1801-7. PubMed ID: 11803400
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum angiogenin levels in ALS.
Cronin S; Greenway MJ; Ennis S; Kieran D; Green A; Prehn JH; Hardiman O
Neurology; 2006 Nov; 67(10):1833-6. PubMed ID: 17130418
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation.
Carilho R; de Carvalho M; Swash M; Pinto S; Pinto A; Costa J
Muscle Nerve; 2014 Apr; 49(4):545-50. PubMed ID: 23868282
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
26. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
Iłecka J
J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
[TBL] [Abstract][Full Text] [Related]
27. [Erythropoietin and vascular endothelial growth factor level in normoxia and in cerebral ischemia under pharmacological and hypoxic preconditioning].
Novikov VE; Levchenkova OS
Biomed Khim; 2020 Jul; 66(4):339-344. PubMed ID: 32893824
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
[TBL] [Abstract][Full Text] [Related]
29. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H
Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible factor expression in human RPE cells.
Forooghian F; Razavi R; Timms L
Br J Ophthalmol; 2007 Oct; 91(10):1406-10. PubMed ID: 17567660
[TBL] [Abstract][Full Text] [Related]
31. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway.
Katavetin P; Miyata T; Inagi R; Tanaka T; Sassa R; Ingelfinger JR; Fujita T; Nangaku M
J Am Soc Nephrol; 2006 May; 17(5):1405-13. PubMed ID: 16597689
[TBL] [Abstract][Full Text] [Related]
32. Phosphoneurofilament heavy chain and vascular endothelial growth factor as cerebrospinal fluid biomarkers for ALS.
Gonçalves M; De Carvalho M; Peixoto C; Alves P; Barreto C; Oliva A; Pinto S; Laborinho-Pronto A; Gromicho M; Costa J
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):134-136. PubMed ID: 27538346
[No Abstract] [Full Text] [Related]
33. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
34. Screening of hypoxia-inducible genes in sporadic ALS.
Cronin S; Greenway MJ; Andersen PM; Hardiman O
Amyotroph Lateral Scler; 2008 Oct; 9(5):299-305. PubMed ID: 18608101
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S
J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043
[TBL] [Abstract][Full Text] [Related]
36. Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors.
Probst-Cousin S; Neundörfer B; Heuss D
Neuromuscul Disord; 2010 Mar; 20(3):192-7. PubMed ID: 20122829
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
[TBL] [Abstract][Full Text] [Related]
38. Absence of mutations in the hypoxia response element of VEGF in ALS.
Gros-Louis F; Laurent S; Lopes AA; Khoris J; Meininger V; Camu W; Rouleau GA
Muscle Nerve; 2003 Dec; 28(6):774-5. PubMed ID: 14639597
[No Abstract] [Full Text] [Related]
39. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
